But if two consecutive tests show TSH below your target, or if a single test shows significant suppression below 0.3 combined with symptoms of overmedication, your prescriber should reduce the dose
Providers can review individual kidney function, stomach ulcer risk factors, and concurrent medications to establish personalized safety guidelines
Gender difference in cardiovascular outcomes with SGLT-2 inhibitors and GLP-1 receptor agonist in type 2 diabetes: A systematic review and meta-analysis of cardio-vascular outcome trials
A new study presented at ENDO 2025 , the annual meeting of the Endocrine Society held in San Francisco, provides compelling evidence that anti-obesity medications may offer an effective intervention
GHK-Cu vs BPC-157 for Tendons, Ligaments & Muscle If the goal is tendon, ligament, muscle, joint, or orthopedic-style recovery research, GHK-Cu vs BPC-157 usually leans toward BPC-157
For individuals experiencing muscle cramps or low energy levels during GLP-1 treatment, magnesium supplements may provide a welcome boost